The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: Omalizumab     Injury: Maternal exposure during pregnancy     Quarter: 2016Q3

  |<   1/2   << Previous Page   Page 1  

Total Records: 4     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
107473699 Omalizumab Maternal exposure during pregnancy ROCHE 36.20 YR F 0 20160826 US
122177492 Omalizumab Maternal exposure during pregnancy ROCHE 0.00 F 0 20160725 GB
122702492 Omalizumab Maternal exposure during pregnancy ROCHE 25.00 YR F 0 20160728 PL
1021304819 Omalizumab Maternal exposure during pregnancy ROCHE 32.59 YR F 45 KG 20160825 US

  |<   1/2   << Previous Page   Page 1  

Total Records: 4     Number of Pages: 1

Execution Time: 0.015491008758545 seconds (ucode:4972958). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.